Oligodendrocytes have a significant role in the rapid action potential transmission by myelination of the neuronal axons in the central nervous system (
6). Glioblastomas, the most frequent glial malignancies, are highly heterogeneous phenotypically and may be presented as glial tumors or GBM with oligodendroglial features. Because of the chemo-sensitivity of GBM-ODG, differentiation of this type of tumor from GBM is essential for therapeutic purposes (
13). Current diagnostics methods for differential diagnosis of brain tumors rely on surgical biopsy, a highly invasive procedure prone to errors when taking the sample (
14). Recently, radiologic diagnostic methods have been prominent due to minimal invasive properties and repeatability without causing irreversible effects.
The present study showed flair or enhanced images, using MRI technique, could not differentiate between GBM-ODG and GBM alone tumors when considering ADC values after obtaining FOH features. However, some of the FOH features obtained from MRIs of edematous regions of the tumoral periphery were competent in distinguishing GBM-ODG from GBM tumors. In addition, the current study reached some cut-off points that could be of choice in clinical decisions. Other studies reported the usability of FOH features in differential diagnosis (
15-
21). Sometimes and after confirmatory studies, these cut-off points could be regarded as definitive biomarkers, as emphasized by other studies (
2,
22).
GBM-ODG is different from GBM when exploring tumor suppressor genes and oncogenes or cytological properties, using molecular and pathological methods, respectively (
13). Diagnosis methods based on molecular or cytological properties of the tissues need surgical interventions. However, the results of the current study showed that the less invasive procedure of MRI could effectively distinguish two types of malignancies with at least 70% sensitivity or specificity for FOH feature cut-off points. Lu et al. showed that peritumoral edema ADC statistics are valuable in distinguishing metastatic brain tumors from gliomas. Their results agree with the current study's findings for differentiating GBM-ODG from GBM without ODG components using MRIs from peritumoral regions (
11). Also, Lu et al.'s study did not propose any cut-off point for differential diagnosis of edema or tumor types, but we reported some cut-off points, using ROC analysis.
Jenkinson et al. showed that ADC and ADC transition coefficient values of FOH features, the mean and maximum or ATC, significantly differed between oligodendroglial tumors when considering their genotypes but not subtypes or grades (
8). However, Jenkinson et al.'s study did not report any cut-off value for differential diagnosis of oligodendroglial tumors, whereas they declare that the outcomes are confirmed, using the molecular method. In the current research, some proper cut-offs for discrimination of GBM-ODG from GBM tumors without ODG components were reported.
Jenkinson et al. (2010) reported that the minimum and maximum ADC values were not different when comparing the cellular density of the tumors, and oligoastrocytomas had lower minimum cell density compared to oligodendrogliomas; also, the cellularity of the tumors using microscopic evaluations was reported (
7). This report agrees with the current study's results about the inability of FOH features obtained from MRIs of tumoral regions or MRIs of T1W to distinguish between GBM-ODG and GBM. Despite the effects of the tumor and T1W MRIs, peritumoral MRIs showed FOHs with somewhat valuable cut-offs with good sensitivity and specificity to the differential diagnosis of mentioned malignancies.
The current study confirms the usability of cut-off values in differentiating the tumor types. Chen et al. evaluated the diagnostic value of Minimum ADC values in predicting neuroepithelial tumor grading. They showed that minimum ADC values significantly differed between low-grade and high-grade gliomas. Also, there was a significant difference between minimum ADC values when grading was performed according to the World Health Organization (WHO) criteria. According to the WHO grading system, some cut-off values for discriminating low-grade from high-grade, G2 from G3, and G3 from G4 gliomas were reported (
10).
Moreover, Fellah et al. reported that ADC values could distinguish Grade II from Grade III oligodendroglial tumors (
23). The current study reported some cut-off values with enough sensitivity and specificity to differentiate GBM-ODG from GBM. However, Fellah et al.'s study showed significant results for the MRIs of tumor tissues. In contrast, the main significant developments in the current research were from the peritumoral edematous regions of the GBM-ODG or GBM tumors. Furthermore, in the present study, 6 FOH features for distinguishing GBM-ODG from GBM were shown; indeed, more diagnostic markers help more precise differential diagnosis, and this aspect of the current research potentiates the results.
Khayal et al. reported that normalized ADC values could distinguish oligodendroglioma from oligoastrocytomas with 91% sensitivity and 92% specificity (
14). The results of the current study revealed that there were some FOHs for differential diagnosis of GBM-ODG from GBM with up to 99.9% sensitivity and 99.7% specificity regarding cut-off values. Khayal et al. considered the median criterion <1.8 or >1.8 as the cut-off for distinguishing between oligodendroglioma and oligoastrocytomas or mixed types (
14). They relied on the median values of tumors and T1W, but we did not observe good results from these types of MRI; however, the results were considered in the MRI from peritumoral edematous regions. Then, edematous areas of tumors contain valuable and informative data about the type of tumor and contents as we differentiate GBM-ODG from GBM using such information. The logic of such a finding arises from the fact that the cellularity or behavior of tumoral content depends on the cell types that form the tumoral lesion (
6,
9,
10,
14,
23,
24).
5.1. Conclusions
The most crucial information that could be conclusive in the current study included the important data obtained from MRIs of the peritumoral edematous regions, but not in tumor or T1W+GAD ones, and compassionate and specific cut-off values for differential diagnosis of GBM-ODG from GBM without ODG components. However, more studies about the importance of peritumoral edemas should be performed in future years to make evidence containing valuable information for neurology professionals, who decide to start the treatment or a neurosurgeon who is preparing to make an operation. However, a comparison between GBM with or without ODG components and other types of brain tumors should be performed to explore the potential usage of FOH statistics values in the differential diagnosis of brain tumors. This report could be considered good evidence for such types of surveys.